Selank 10mg Research Peptide
Selank is a synthetic heptapeptide analogue of the endogenous immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg), extended with a Pro-Gly-Pro tripeptide sequence to enhance metabolic stability and broaden its biological activity profile. Developed by the Institute of Molecular Genetics of the Russian Academy of Sciences, Selank has been studied extensively for anxiolytic, nootropic, and immunomodulatory effects in both preclinical and clinical research settings. This 10mg lyophilized vial provides research-grade Selank at ≥99% purity, HPLC and MS/MS verified per batch, for use across a range of neurological and immunological research protocols.
Research Background
Selank’s anxiolytic mechanism is distinct from classical benzodiazepines — it modulates GABA-A receptor subunit expression and interacts with the enkephalin degradation system rather than directly binding benzodiazepine receptor sites, producing anxiolytic effects in preclinical models without sedation, tolerance, or dependence. Russian clinical studies have documented significant anxiety and irritability score reductions in generalized anxiety disorder patients with a favorable tolerability profile. Immunological effects via tuftsin receptor activation on monocytes and macrophages add a second research dimension distinct from its CNS activity.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 10mg per vial
- Storage: −20°C, protected from light
- Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
- Molecular Weight: 863.0 Da
Certificate of Analysis
All Selank vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
